← Leaderboards
Franck Barrat
Dynavax Technologies Corporation
$2,920,339
Attributed
$2,920,339
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $440K · FY2009–22$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,920,339 · 2
By mechanism
R01$2,200,000 · 1
R43$720,339 · 1
Top collaborators
No co-investigators on record.
Most similar at Dynavax Technologies Corporation
Same institution · by research overlap
- Cristiana Guiducci$1,613,878
- Albert F Candia$1,123,962
- Robert L Coffman$6,700,309
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelReceptorLeadMediatingOrganProductionInflammationInterferonsDendritic CellsLupusAutoimmunityNucleic AcidsPathogenesisPharmaceutical PreparationsDendritic Cell ActivationCellsCell TypeInterferon-AlphaChronicAutoimmune DiseasesDisease ModelDermatomyositisCutaneousSignal Transduction
Grant awards (7)
Role of plasmacytoid dendritic cells in autoimmunity$440,000
R01 · FY2022 · AI · contact PI
Role of plasmacytoid dendritic cells in autoimmunity$440,000
R01 · FY2021 · AI · contact PI
Role of plasmacytoid dendritic cells in autoimmunity$440,000
R01 · FY2020 · AI · contact PI
Role of plasmacytoid dendritic cells in autoimmunity$440,000
R01 · FY2019 · AI · contact PI
Role of plasmacytoid dendritic cells in autoimmunity$440,000
R01 · FY2018 · AI · contact PI
Inhibitors of Toll-like receptors 7 & 9 for treatment of skin inflammation$360,909
R43 · FY2010 · AI · contact PI
Inhibitors of Toll-like receptors 7 & 9 for treatment of skin inflammation$359,430
R43 · FY2009 · AI · contact PI